Rituximab reduces anti-cardiolipin levels in patients with systemic lupus erythematosus

From: 5th European Workshop on Immune-Mediated Inflammatory Diseases Sitges-Barcelona, Spain 1-3 December 2010 Author details 1-Rheumatology Unit, Valme University Hospital, Seville, Spain EMPTY 2-Rheumatology Unit, Malaga Civil Hospital, Malaga, Spain EMPTY 3-Rheumatology Unit, Gregorio Marañón U...

Full description

Saved in:
Bibliographic Details
Published in:Journal of translational medicine 2010-11, Vol.8 (S1), p.P69-P69, Article P69
Main Authors: Martínez-Pérez, R, Muñoz-Jiménez, A, Rodríguez-Montero, S, Fernández-Nebro, A, Carreño, L, Marenco, J L
Format: Article
Language:English
Subjects:
Autoimmune diseases
Immune system
Lupus
Poster Presentation
Rheumatology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:From: 5th European Workshop on Immune-Mediated Inflammatory Diseases Sitges-Barcelona, Spain 1-3 December 2010 Author details 1-Rheumatology Unit, Valme University Hospital, Seville, Spain EMPTY 2-Rheumatology Unit, Malaga Civil Hospital, Malaga, Spain EMPTY 3-Rheumatology Unit, Gregorio Marañón University Hospital, Madrid, SpainEMPTY Supplemental Information: Meeting abstracts - A single PDF containing all abstracts in this Supplement is available at http://www.biomedcentral.com/content/files/pdf/1479-5876-8-S1-full.pdf.EMPTYUrl: http://www.biomedcentral.com/content/pdf/1479-5876-8-S1-info.pdf Introduction Patients with systemic lupus erythematosus (SLE), can produce antibodies directed against the complex phospholipds-β-glycoprotein 1.
ISSN:1479-5876
1479-5876
DOI:10.1186/1479-5876-8-S1-P69